Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Quoin Pharmaceuticals Ltd
Cash from Operating Activities
Quoin Pharmaceuticals Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Cash from Operating Activities
-$7.5m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
Compugen Ltd
NASDAQ:CGEN
|
Cash from Operating Activities
-$32.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-18%
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Cash from Operating Activities
-₪9.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
See Also
What is Quoin Pharmaceuticals Ltd's Cash from Operating Activities?
Cash from Operating Activities
-7.5m
USD
Based on the financial report for Mar 31, 2024, Quoin Pharmaceuticals Ltd's Cash from Operating Activities amounts to -7.5m USD.
What is Quoin Pharmaceuticals Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-2%
Over the last year, the Cash from Operating Activities growth was 7%. The average annual Cash from Operating Activities growth rates for Quoin Pharmaceuticals Ltd have been -22% over the past three years , -2% over the past five years .